Fetal and Neonatal Heart Monitor Market: Concerted Efforts to Reduce Preterm Births Driving Adoption in Hospitals and Neonatal Clinics
Verfasser: ashwani_kailiya on Tuesday, 29 May 2018Global sales of fetal and neonatal heart monitors are likely to surpass 261,000 units in 2018, with rising adoption in the US driving sales. Cardiotocographs remain the highest selling fetal and neonatal heart monitor devices, with global sales equating a valuation of nearly US$ 400 Mn in 2017. Demand continues to remain concentrated in hospitals and neonatal clinics, with the former accounting for a leading share.
The fetal and neonatal heart monitors continue to be driven by efforts to mitigate the number of preterm births. Data from National Center for Health Statistics show that the US has a high infant mortality rate among developed economies. The number of deaths per live births also remains a concern in Europe, with governments and healthcare providers in the United Kingdom, France, Germany, and Italy working towards mitigating the numbers.
Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=750
The report finds that Asia Pacific excluding Japan (APEJ) will emerge as a lucrative market for the fetal and neonatal heart monitor manufacturers during the assessment period. Many countries in the region have high infant mortality rates, and there has been a concerted effort by governments and healthcare providers to improve the situation.